Kotchetkov R, Drennan IR, Susman D, DiMaria E, et al. Bendamustine and rituximab is well-tolerated and efficient in the treatment of indolent non-Hodgkin's lymphoma and Mantle Cell Lymphoma in elderly: A single center observational study. Int J Cancer 2022 Dec 22. doi: 10.1002/ijc.34412.
PMID: 36545885